GlassScriptPhysician profile
Archana Sood
NPI 1598879181
$443.79
in general payments reported to CMS, 2019-2025
9 companies · $24.82 in 2025
The $24.82 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $121 · 2021: $23.87 · 2022: $80.85 · 2024: $44.98 · 2025: $24.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $153.86 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $61.83 | 2021-2024 | Breztri |
| Allergan, INC. | $57.34 | 2019-2020 | |
| Sanofi Pasteur INC. | $45.69 | 2019-2021 | |
| Pfizer INC. | $43.99 | 2019-2022 | |
| Amgen INC. | $30.54 | 2020 | |
| Glaxosmithkline, LLC. | $25.22 | 2020 | |
| Medtronic, INC. | $13.61 | 2022 | |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Archana Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.